Vistagen Therapeutics, Inc. - Common Stock (NQ:VTGN)

0.2810 -0.0016 (-0.57%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vistagen Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Schedules Release of Q2 Results, Corporate Update Conference Call

November 06, 2023

Via Investor Brand Network

Vistagen To Report Second Quarter Financial Results and Host Corporate Update Conference Call on November 9, 2023

November 06, 2023

From Vistagen

Via Business Wire

Why Vistagen Therapeutics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

October 17, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares surged 79.5% to $5.08 in pre-market trading after falling around 7% on Monday. SciSparc recently regained compliance with the Nasdaq Minimum Bid Price...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

October 17, 2023

It's time for another dive into the biggest pre-market stock movers as we list out the top stocks worth watching on Tuesday!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 05, 2023

Via Benzinga

InvestorNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) Announces Participation in Inaugural Biotech CNS/Neuro Summit

October 05, 2023

Via Investor Brand Network

Vistagen to Present at Jefferies Inaugural Biotech CNS/Neuro Summit

October 05, 2023

From Vistagen

Via Business Wire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 02, 2023

Via Benzinga

Why Intelligent Bio Solutions Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

October 02, 2023

Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares climbed 86.1% to $0.2248 after the company said it is considering strategic alternatives for its non-core operations.

Via Benzinga

InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Pricing of $100M Underwritten Offering

October 02, 2023

Via Investor Brand Network

Vistagen Announces Pricing of $100 Million Underwritten Offering

October 02, 2023

From Vistagen Therapeutics, Inc.

Via Business Wire

The 7 Best Short-Squeeze Stocks to Buy Now: September 2023 ↗

September 21, 2023

Explore the potential of the best short-squeeze stocks to buy now as companies attempt to prove pessimistic traders wrong.

Via InvestorPlace

InvestorNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) Reports on Phase 2A Study Results Regarding Treatment of Premenstrual Dysphoric Disorder

September 12, 2023

Via Investor Brand Network

Vistagen Announces Positive Results from Exploratory Phase 2A Study of PH80 for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder

September 12, 2023

From Vistagen

Via Business Wire

10 Short Squeeze Stocks To Watch: Getty Images, Bitcoin Depot, Blue Apron Holdings And More ↗

September 11, 2023

Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of traders looking for the next huge move. High short interest and steep borrowing costs are among the...

Via Benzinga

InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN), Fuji Pharma Co. Ltd. (TSE: 4554) Announce Exclusive Negotiation Agreement

September 05, 2023

Via Investor Brand Network

10 Short Squeeze Stocks To Watch: Blue Apron, Getty Images, Black Rifle Coffee And More ↗

September 05, 2023

Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a new focus of traders looking for the next huge move. High short interest and steep borrowing costs are among...

Via Benzinga

Vistagen and Fuji Enter Exclusive Negotiation Agreement for a Potential License to Develop and Commercialize Vistagen’s Investigational Menopausal Hot Flash Therapy, PH80 Nasal Spray, in Japan

September 05, 2023

From Vistagen

Via Business Wire

10 Short Squeeze Stocks To Watch: Getty Images, Blue Apron, T Stamp, Black Rifle Coffee And More ↗

August 28, 2023

Via Benzinga

InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Appoints Highly Accomplished Finance Professional as CFO

August 22, 2023

Via Investor Brand Network

Topics Retirement

Vistagen Appoints Cindy Anderson as Chief Financial Officer

August 22, 2023

From Vistagen

Via Business Wire

InvestorNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) Releases Q1 2024 Financial Report, Corporate Update

August 11, 2023

Via Investor Brand Network

Subsequent to the Release of Positive Phase 3 Trial Results, Vistagen Provides Corporate Update and Reports Fiscal 2024 First Quarter Financial Results

August 10, 2023

From Vistagen

Via Business Wire

Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

August 10, 2023

Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 10, 2023

Via Benzinga

Why AppLovin Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket ↗

August 10, 2023

Gainers PHAXIAM Therapeutics S.A. (NASDAQ: PHXM) shares surged 46.7% to $0.64 in pre-market trading after gaining 6% on Wednesday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

August 10, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders should watch on Thursday morning!

Via InvestorPlace

$18M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying ↗

August 10, 2023

Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.

Via Benzinga

Earnings Scheduled For August 10, 2023 ↗

August 10, 2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 09, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.